Yukitoshi Takahashi Selected Research

Yukitoshi Takahashi Research Topics

Disease

45	Encephalitis (Encephalitis, Rasmussen) 05/2022 - 08/2003
41	Seizures (Absence Seizure) 05/2022 - 03/2003
41	Epilepsy (Aura) 01/2022 - 03/2003
31	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2021 - 09/2005
13	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 01/2017
12	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2020 - 11/2008
9	Drug Resistant Epilepsy 01/2020 - 06/2003
9	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020 - 01/2008
9	Brain Diseases (Brain Disorder) 07/2016 - 10/2005
7	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2021 - 01/2010
7	Leukocytosis (Pleocytosis) 09/2016 - 10/2007
6	Spasm (Spasms) 01/2022 - 07/2011
6	Neoplasms (Cancer) 01/2021 - 01/2007
6	Hyperammonemia 12/2019 - 09/2012
6	Ovarian Teratoma 05/2017 - 01/2007
6	Infections 08/2015 - 01/2004
6	Disease Progression 07/2015 - 09/2005
6	Status Epilepticus (Complex Partial Status Epilepticus) 07/2015 - 06/2003
6	Cerebellar Ataxia (Dysmetria) 10/2013 - 06/2003
5	Body Weight (Weight, Body) 01/2022 - 04/2015
5	Infantile Spasms (West Syndrome) 01/2022 - 05/2012
5	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 07/2011
5	Epilepsia Partialis Continua 09/2011 - 08/2003
4	Autoimmune Diseases of the Nervous System 01/2021 - 07/2007
4	Angiomyolipoma 01/2020 - 01/2017
4	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2017
4	Drug-Related Side Effects and Adverse Reactions 01/2018 - 02/2010
4	Ataxia (Dyssynergia) 03/2017 - 05/2007
4	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 04/2014 - 10/2012
3	Demyelinating Diseases (Demyelinating Disease) 05/2022 - 11/2014
3	Temporal Lobe Epilepsy 01/2022 - 06/2007
3	Myoclonus (Nocturnal Myoclonus) 10/2020 - 07/2007
3	Nervous System Diseases (Neurological Disorders) 10/2020 - 11/2013
3	Inflammation (Inflammations) 12/2018 - 07/2015
3	Teratoma (Teratoid Tumor) 05/2017 - 01/2010
3	Virus Diseases (Viral Diseases) 03/2016 - 03/2011
3	Relapsing Polychondritis 01/2015 - 12/2009
3	Meningoencephalitis 01/2014 - 01/2008
2	Focal cortical dysplasia of Taylor 01/2022 - 07/2021
2	CDKL5 deficiency disorder 04/2021 - 01/2017
2	Cognitive Dysfunction 01/2021 - 09/2014
2	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 09/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 05/2017

Drug/Important Bio-Agent (IBA)

58	Glutamate Receptors (Glutamate Receptor)IBA 01/2021 - 06/2003
52	AntibodiesIBA 05/2022 - 06/2003
36	AutoantibodiesIBA 01/2021 - 01/2005
20	Anticonvulsants (Antiepileptic Drugs)IBA 07/2021 - 11/2006
17	N-Methylaspartate (NMDA)IBA 12/2020 - 01/2005
16	Carbamazepine (Tegretol)FDA LinkGeneric 12/2019 - 08/2005
16	Phenytoin (Dilantin)FDA LinkGeneric 12/2018 - 01/2011
14	trans-sodium crocetinate (crocetin)IBA 01/2021 - 01/2017
14	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 07/2008
13	SteroidsIBA 01/2021 - 01/2004
13	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 06/2003
12	Phenobarbital (Luminal)FDA Link 12/2019 - 06/2003
11	CytokinesIBA 10/2015 - 10/2008
10	NR2B NMDA receptorIBA 08/2010 - 08/2003
9	Methylprednisolone FDA LinkGeneric 01/2021 - 05/2007
8	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022 - 09/2011
8	Pharmaceutical PreparationsIBA 01/2022 - 02/2010
8	Clobazam (HR 376)IBA 01/2020 - 06/2005
7	perampanelIBA 10/2021 - 01/2017
7	EpitopesIBA 09/2014 - 01/2005
6	Topiramate (Topamax)FDA LinkGeneric 01/2018 - 07/2010
6	Intravenous Immunoglobulins (IVIG)FDA Link 02/2017 - 01/2004
6	Proteins (Proteins, Gene)FDA Link 01/2014 - 07/2008
5	AmmoniaIBA 12/2015 - 09/2012
5	Glutamic Acid (Glutamate)FDA Link 12/2015 - 03/2011
5	Immunoglobulin G (IgG)IBA 04/2013 - 05/2007
4	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 07/2013
4	stiripentolIBA 01/2020 - 11/2009
4	Cytochrome P-450 CYP2C19IBA 01/2020 - 01/2011
4	EnzymesIBA 12/2018 - 01/2012
4	Prednisolone (Predate)FDA LinkGeneric 02/2017 - 02/2008
4	Immunoglobulins (Immunoglobulin)IBA 07/2016 - 06/2005
4	ChemokinesIBA 10/2015 - 11/2014
4	HLA-B Antigens (HLA-B)IBA 04/2014 - 11/2008
4	erucylphosphocholineIBA 09/2011 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2020 - 09/2014
3	Uridine Diphosphate (UDP)IBA 03/2017 - 06/2014
3	Tacrolimus (Prograf)FDA LinkGeneric 09/2016 - 11/2007
3	Cytochrome P-450 CYP2C9IBA 04/2015 - 01/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 10/2008
3	Zonisamide (Zonegran)FDA LinkGeneric 11/2013 - 08/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 10/2007
3	Immunoglobulin M (IgM)IBA 08/2009 - 09/2005
3	glutamate receptor delta 2IBA 02/2008 - 09/2005
3	Ionotropic Glutamate ReceptorsIBA 10/2007 - 09/2005
3	barbituric acid (barbiturate)IBA 10/2007 - 06/2003
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 07/2021
2	rufinamide FDA Link 01/2022 - 01/2017
2	Oligoclonal BandsIBA 01/2021 - 01/2008
2	GlucocorticoidsIBA 01/2021 - 08/2014
2	AntigensIBA 09/2020 - 03/2008

Therapy/Procedure

50	Therapeutics 01/2022 - 03/2003
5	Immunotherapy 03/2020 - 07/2010
3	Ketogenic Diet 03/2018 - 07/2011
3	Aftercare (After-Treatment) 05/2017 - 09/2013
3	Artificial Respiration (Mechanical Ventilation) 01/2011 - 10/2005